Wednesday, April 30th 2008
Oxitec Ltd is pleased to announce that, as part of an international consortium, it is the recipient of a three year World Health Organisation (WHO) grant from The Special Programme for Research and Training in Tropical Diseases (TDR) Innovative Vector Control Business Line. The grant is to engage with countries where dengue fever and malaria are endemic on the use of genetic methods to control the mosquitoes that spread these diseases. The international consortium is led by Dr John Mumford at Imperial College London, and includes Oxitec Ltd, the University of Sao Paolo, Brazil, National Institute of Public Health, Mexico, Gorgas Institute, Panama, Centre for Excellence of Vectors and Vector borne diseases, Mahidol University Thailand and the University of Nairobi. Dr Rachel Rueben who was the founding Director for Research in Medical Entomology in Madurai, India will be acting as Emeritus Professor for the project.
The Special Programme for Research and Training in Tropical Diseases (TDR) is an independent global programme of scientific collaboration. Established in 1975 and co-sponsored by the United Nations Children’s Fund (UNICEF), the United Nations Development Programme (UNDP), the World Bank and the World Health Organization (WHO), it aims to help coordinate, support and influence global efforts to combat a portfolio of major diseases of the poor and disadvantaged.TDR focuses on neglected infectious diseases that disproportionately affect poor and marginalized populations.
Related posts:
- Oxitec wins Small Business Research Initiative grant
- Luke Alphey appointed Visiting Professor at Oxford University
- Oxford, 29 November 2007. The World Economic Forum today announced that Oxitec Limited has been selected as one of 39 Technology Pioneers 2008
- Oxitec appoints Business Development Manager for Asia